home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Virpax Pharmaceuticals, Inc. - Common Stock (NQ:VRPX)

0.6695 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virpax Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

November 17, 2023

From Virpax Pharmaceuticals

Via Business Wire

Virpax Pharmaceuticals Announces Leadership Transition

November 17, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

November 15, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA Review

October 31, 2023

From Virpax Pharmaceuticals

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 17, 2023

Via Benzinga

Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research

October 12, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Gerald W. Bruce Appointed President and CEO of Novvae™ Pharmaceuticals

October 02, 2023

From Virpax Pharmaceuticals

Via Business Wire

Virpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation Studies

September 27, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals to Present at the LD Micro Main Event XVI

September 26, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses

September 21, 2023

From Altasciences

Via Business Wire

Virpax Pharmaceuticals Announces the Formation of Novvae™ Pharmaceuticals

September 18, 2023

From Virpax Pharmaceuticals

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 05, 2023

Via Benzinga

Virpax Pharmaceuticals Updates on Litigation

September 05, 2023

From Virpax Pharmaceuticals

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 31, 2023

Via Benzinga

Virpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

August 28, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

August 14, 2023

From Virpax® Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and Method

August 10, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 24, 2023

Via Benzinga

Virpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023

July 24, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 21, 2023

Via Benzinga

Virpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery

July 13, 2023

From Virpax Pharmaceuticals

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 28, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council

June 21, 2023

From Virpax Pharmaceuticals, Inc.

Via Business Wire

Virpax Pharmaceuticals Announces CFO Transition

June 20, 2023

From Virpax Pharmaceuticals

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com